Literature DB >> 7399695

Temperature-sensitive mutants of influenza A virus: transfer of the two temperature-sensitive lesions in the Udorn/72-ts-1A2 virus to the A2Hong Kong/123/77 (H1N1) wild-type virus.

B R Murphy, N T Hosier, R M Chanock.   

Abstract

The influenza A/Udorn/72-ts-1A2 virus possesses temperature-sensitive mutations in the genes coding for the P1 and P3 polymerase proteins. It is being evaluated as a donor of its attenuating temperature-sensitive genes to produce recombinant live vaccine strains of epidemic variants of influenza A virus. Transfer of the P1 and P3 genes to two viruses within the H3N2 subtype of influenza A virus (i.e., the A/Victoria/3/75 and A/Alaska/6/77 viruses) conferred on each variant the following properties: (i) 37 degrees C shutoff temperature for plaque formation, (ii) almost complete restriction of viral replication in the lungs, (iii) a 100-fold restriction of viral replication in the nasal turbinates, and (iv) genetic stability after replication in hamsters. This study was undertaken to determine whether the transfer of the two ts-1A2 temperature-sensitive genes into a virus belonging to the H1N1 subtype (i.e., the A/Hong Kong/123/77 virus) would result in a restriction of replication in vitro and in vivo comparable to that observed with the previously studied H3N2 recombinant viruses in hamsters. This was found to be the case. In addition, infection of hamsters with the A/Hong Kong/77-ts-1A2 virus induced significant resistance to infection with wild-type A/Hong Kong/77 virus. Thus, the two ts-1A2 temperature-sensitive genes attenuated influenza A viruses belonging to two distinct subtypes to a specific and predictable level. An unexpected genetic interaction was observed between several A/Hong Kong/77-ts-1A2 segregants bearing the group 5 (P1) temperature-sensitive lesion. One interpretation of these results is that intracistronic complementation occurred between these segregants.

Entities:  

Mesh:

Year:  1980        PMID: 7399695      PMCID: PMC551020          DOI: 10.1128/iai.28.3.792-798.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Temperature-sensitive mutants of influenza. VIII. Genetic and biological characterization of TS mutants of influenza virus A (H3N2) and their assignment to complementation groups.

Authors:  S B Spring; S R Nusinoff; E L Tierney; D D Richman; B R Murphy; R M Chanock
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

2.  Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2).

Authors:  S B Spring; S R Nusinoff; J Mills; D D Richman; E L Tierney; B R Murphy; R M Chanock
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

3.  Live attenuated influenza virus vaccines. Strains with temperature-sensitive defects in P3 protein and nucleoprotein.

Authors:  P Palese; M B Ritchey
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

4.  Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children.

Authors:  B R Murphy; D D Richman; S B Spring; R M Chanock
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

5.  Temperature-sensitive mutants of influenza virus. XVI. Transfer of the two ts lesions present in the Udorn/72-ts-1A2 donor virus to the Victoria/3/75 wild-type virus.

Authors:  B R Murphy; F T Wood; J G Massicot; R M Chanock
Journal:  Virology       Date:  1978-07-15       Impact factor: 3.616

6.  Temperature-sensitive mutants of influenza virus. XV. The genetic and biological characterization of a recombinant influenza virus containing two ts lesions produced by mating two complementing, single lesion ts mutants.

Authors:  B R Murphy; F T Wood; J G Massicot; S B Spring; R M Chanock
Journal:  Virology       Date:  1978-07-15       Impact factor: 3.616

7.  Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.

Authors:  B R Murphy; R M Chanock; M M Levine; G A van Blerk; E J Berquist; R G Douglas; R F Betts; R B Couch; T R Cate
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  Temperature-sensitive mutants of influenza virus. Identification of the loci of the two ts lesions in the Udorn-ts-1A2 donor virus and the correlation of the presence of these two ts lesions with a predictable level of attenuation.

Authors:  J G Massicot; B R Murphy; F Thierry; L Markoff; K Y Huang; R M Chanock
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

9.  Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain.

Authors:  S B Spring; H F Maassab; A P Kendal; B R Murphy; R M Chanock
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

10.  Temperature-sensitive mutants of influenza A virus. XI. Transfer of ts lesions in the Hong Kong/68-ts-1 [a] virus to the influenza A/Udorn/72 wild type.

Authors:  B R Murphy; E L Tierney; S B Spring; R M Chanock
Journal:  J Infect Dis       Date:  1976-12       Impact factor: 5.226

View more
  2 in total

1.  Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses.

Authors:  M D Tolpin; M L Clements; M M Levine; R E Black; A J Saah; W C Anthony; L Cisneros; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

2.  Production and level of genetic stability of an influenza A virus temperature-sensitive mutant containing two genes with ts mutations.

Authors:  B R Murphy; L J Markoff; N T Hosier; J G Massicot; R M Chanock
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.